MFN2 and Cognitive impairment: To address these questions, we established a mouse model of diabetes-associated cognitive impairment and a complementary in vitro model of high-glucose-induced hippocampal synaptic plasticity impairment, and found that under high-glucose conditions, Mfn2-regulated MAM architectural and numerical abnormalities provoke hippocampal plasticity impairment.